Halozyme proposes $1.05 billion convertible notes offering

Go back to Halozyme proposes $1.05 billion convertible notes offering
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 111.45 --0 (-0%)
Previous Close $111.45    52 Week High $18.39 
Open $111.45    52 Week Low $6.96 
Day High $111.45    P/E N/A 
Day Low $111.45    EPS $-0.58 
Volume 295